ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

BUROSUMABUM

Active substance (INN) · ATC M05BX05 · 3 products authorised in Romania

◀ Back

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

Code	Protocol	Status	Role	Sublist	GP
M05BX05	BUROSUMABUM	In force	medicine of the protocol	C1-G22	NO

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand name	Form	Strength	Holder	ATC	Rx
CRYSVITA 10 mg	SOL. INJ.	10mg/ml	KYOWA KIRIN HOLDINGS B.V. - OLANDA	M05BX05	PR
CRYSVITA 10 mg	SOL. INJ. IN SERINGA PREUMPLUTA	30mg/ml	KYOWA KIRIN HOLDINGS B.V. - OLANDA	M05BX05	PR
CRYSVITA 20 mg	SOL. INJ.	20mg/ml	KYOWA KIRIN HOLDINGS B.V. - OLANDA	M05BX05	PR
CRYSVITA 20 mg	SOL. INJ. IN SERINGA PREUMPLUTA	30mg/ml	KYOWA KIRIN HOLDINGS B.V. - OLANDA	M05BX05	PR
CRYSVITA 30 mg	SOL. INJ.	30mg/ml	KYOWA KIRIN HOLDINGS B.V. - OLANDA	M05BX05	PR
CRYSVITA 30 mg	SOL. INJ. IN SERINGA PREUMPLUTA	30mg/ml	KYOWA KIRIN HOLDINGS B.V. - OLANDA	M05BX05	PR

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.